OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."
The author discusses potential manufacturing costs & challenges of allogeneic & autologous stem-cell therapy.
Eighty drugs will lose patent protection between 2007 and 2011.